![Figure 6, Treatment Nodes for Complete Response: Moderately Emetogenic Chemotherapy Overall Phase Indirect Comparison - Clinical Review Report: Netupitant/Palonosetron 300 mg/0.5 mg (Akynzeo) - NCBI Bookshelf Figure 6, Treatment Nodes for Complete Response: Moderately Emetogenic Chemotherapy Overall Phase Indirect Comparison - Clinical Review Report: Netupitant/Palonosetron 300 mg/0.5 mg (Akynzeo) - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK533939/bin/clapp6f5.jpg)
Figure 6, Treatment Nodes for Complete Response: Moderately Emetogenic Chemotherapy Overall Phase Indirect Comparison - Clinical Review Report: Netupitant/Palonosetron 300 mg/0.5 mg (Akynzeo) - NCBI Bookshelf
![Replacing YIG-Tuned Oscillators with Silicon by Using an Ultrawideband PLL/VCO with Precision Phase Control | アナログ・デバイセズ Replacing YIG-Tuned Oscillators with Silicon by Using an Ultrawideband PLL/VCO with Precision Phase Control | アナログ・デバイセズ](https://www.analog.com/-/media/analog/en/landing-pages/technical-articles/replacing-yig-tuned-oscillators-with-silicon/figure4.png?w=900&la=ja&imgver=1)
Replacing YIG-Tuned Oscillators with Silicon by Using an Ultrawideband PLL/VCO with Precision Phase Control | アナログ・デバイセズ
![Palonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trials | Future Oncology Palonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trials | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.13.153/asset/images/medium/figure1.gif)
Palonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trials | Future Oncology
![Reliability and validity of the Physical Activity Scale for the Elderly ( PASE) in patients with hip osteoarthritis | BMC Musculoskeletal Disorders | Full Text Reliability and validity of the Physical Activity Scale for the Elderly ( PASE) in patients with hip osteoarthritis | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1471-2474-13-26/MediaObjects/12891_2011_Article_1334_Fig2_HTML.jpg)
Reliability and validity of the Physical Activity Scale for the Elderly ( PASE) in patients with hip osteoarthritis | BMC Musculoskeletal Disorders | Full Text
![A phase II, randomized study of aprepitant in the prevention of chemotherapy‑induced nausea and vomiting associated with moderately emetogenic chemotherapies in colorectal cancer patients A phase II, randomized study of aprepitant in the prevention of chemotherapy‑induced nausea and vomiting associated with moderately emetogenic chemotherapies in colorectal cancer patients](https://www.spandidos-publications.com/article_images/mco/4/3/mco-04-03-0393-g01.jpg)
A phase II, randomized study of aprepitant in the prevention of chemotherapy‑induced nausea and vomiting associated with moderately emetogenic chemotherapies in colorectal cancer patients
![Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial† - Annals of Oncology Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8eae1f95-5cd7-46e4-9c02-77594f27e2f1/gr2_lrg.jpg)
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial† - Annals of Oncology
![Patient-related Risk Factors for Nausea and Vomiting With Standard Antiemetics in Patients With Cancer Receiving Carboplatin: A Retrospective Study - Clinical Therapeutics Patient-related Risk Factors for Nausea and Vomiting With Standard Antiemetics in Patients With Cancer Receiving Carboplatin: A Retrospective Study - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a2a2d4ce-4503-461c-a0d9-801de5678551/gr2_lrg.jpg)
Patient-related Risk Factors for Nausea and Vomiting With Standard Antiemetics in Patients With Cancer Receiving Carboplatin: A Retrospective Study - Clinical Therapeutics
![Nanomaterials | Free Full-Text | Scattering Analysis and Efficiency Optimization of Dielectric Pancharatnam–Berry-Phase Metasurfaces | HTML Nanomaterials | Free Full-Text | Scattering Analysis and Efficiency Optimization of Dielectric Pancharatnam–Berry-Phase Metasurfaces | HTML](https://www.mdpi.com/nanomaterials/nanomaterials-11-00586/article_deploy/html/images/nanomaterials-11-00586-g004.png)